AhR expression is increased in hepatocellular carcinoma.
about
The aryl hydrocarbon receptor meets immunology: friend or foe? A little of bothCytoplasmic aryl hydrocarbon receptor regulates glycogen synthase kinase 3 beta, accelerates vimentin degradation, and suppresses epithelial-mesenchymal transition in non-small cell lung cancer cells.Aryl hydrocarbon receptor ligands in cancer: friend and foe.An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER-/PR-/Her2- Human Breast Cancer CellsAryl hydrocarbon receptor regulates histone deacetylase 8 expression to repress tumor suppressive activity in hepatocellular carcinomaThe RNA-binding protein Sam68 regulates tumor cell viability and hepatic carcinogenesis by inhibiting the transcriptional activity of FOXOs.Upregulated expression of ubiquitin-conjugating enzyme E2Q1 (UBE2Q1) is associated with enhanced cell proliferation and poor prognosis in human hapatocellular carcinoma.The effect of CXCL9 on the invasion ability of hepatocellular carcinoma through up-regulation of PREX2.Decreased expression of SERPINB1 correlates with tumor invasion and poor prognosis in hepatocellular carcinoma.The interleukin-6-type cytokine oncostatin M induces aryl hydrocarbon receptor expression in a STAT3-dependent manner in human HepG2 hepatoma cells.Aryl hydrocarbon receptor promotes hepatocellular carcinoma tumorigenesis by targeting intestine-specific homeobox expression.AHR/CYP1A1 interplay triggers lymphatic barrier breaching in breast cancer spheroids by inducing 12(S)-HETE synthesis.The Aryl Hydrocarbon Receptor and Tumor Immunity.Cell expression patterns of CD147 in N-diethylnitrosamine/phenobarbital-induced mouse hepatocellular carcinoma.The expression of HER-2/neu (c-erbB2), survivin and cycline D1 in serous ovarian neoplasms: their correlation with clinicopathological variables.
P2860
Q26851740-30DA4C22-C62E-4490-9819-DF633F6F0B1FQ33586399-9F6E28F1-093F-4768-9A4C-FC11E54A160DQ35458027-6D029613-19DD-4C6C-A0EC-9127A9BDE113Q37357710-2987466B-161F-46E4-85B2-92677978D6B9Q37702550-9BA3AAD7-5D23-4845-8B92-C85A47C1AF37Q38830141-58ED3DEA-204E-457D-B9EF-0406A215B763Q38948216-20BE42D6-CC82-4836-8ADD-8A0D0491636FQ38963362-E51530AC-886E-4121-A7FA-26B7D6697241Q39084439-1C351048-6C6C-44CE-883E-9134D21206E5Q42446604-732A3867-C10B-450C-BBCD-8768D180D8CEQ48290594-8D668676-36FD-41ED-8568-9B7BCB1CEB0BQ48633969-A7045796-6679-42FE-A7A0-31374A5B7EA4Q50327400-48E91D96-37E1-4B90-9912-2B19C7FB5938Q53378750-446E4AC3-D6FC-4294-AA98-57AF0FF5C796Q54332089-880D30ED-38D0-422C-8ADF-73AE8DAFFCC3
P2860
AhR expression is increased in hepatocellular carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
AhR expression is increased in hepatocellular carcinoma.
@en
AhR expression is increased in hepatocellular carcinoma.
@nl
type
label
AhR expression is increased in hepatocellular carcinoma.
@en
AhR expression is increased in hepatocellular carcinoma.
@nl
prefLabel
AhR expression is increased in hepatocellular carcinoma.
@en
AhR expression is increased in hepatocellular carcinoma.
@nl
P2093
P2860
P1476
AhR expression is increased in hepatocellular carcinoma.
@en
P2093
Fanglin Zhang
Guoqiang Bao
Lurong Han
Xing'an Wu
P2860
P304
P356
10.1007/S10735-013-9495-6
P577
2013-04-02T00:00:00Z